These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35533035)

  • 41. [Treatment of palmar and axillary hyperhidrosis: thoracoscopic resection of the sympathetic chain].
    Rieger R; Pedevilla S; Pöchlauer S
    Chirurg; 2008 Dec; 79(12):1151-61. PubMed ID: 18523743
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Open clinical trial for evaluation of efficacy and safety of a portable "dry-type" iontophoretic device in treatment of palmar hyperhidrosis.
    Choi YH; Lee SJ; Kim DW; Lee WJ; Na GY
    Dermatol Surg; 2013 Apr; 39(4):578-83. PubMed ID: 23379993
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case of isolated axillary hyperhidrosis successfully treated topically with 1% glycopyrronium cream.
    Sega-Hall GM; Smith P; Haworth AE
    Clin Exp Dermatol; 2006 Nov; 31(6):825. PubMed ID: 17040271
    [No Abstract]   [Full Text] [Related]  

  • 44. A phase 2a randomized controlled study to evaluate the pharmacokinetic, safety, tolerability and clinical effect of topically applied Umeclidinium in subjects with primary axillary hyperhidrosis.
    Nasir A; Bissonnette R; Maari C; DuBois J; Pene Dumitrescu T; Haddad J; Yamaguchi Y; Dalessandro M
    J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):145-151. PubMed ID: 29055158
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A double-blind, randomized, comparative study of Dysport vs. Botox in primary palmar hyperhidrosis.
    Simonetta Moreau M; Cauhepe C; Magues JP; Senard JM
    Br J Dermatol; 2003 Nov; 149(5):1041-5. PubMed ID: 14632812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Uniportal endoscopic thoracic sympathectomy for treatment of palmar and axillary hyperhidrosis: analysis of 2000 cases.
    Lin TS; Kuo SJ; Chou MC
    Neurosurgery; 2002 Nov; 51(5 Suppl):S84-7. PubMed ID: 12234434
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
    Vergilis-Kalner IJ
    J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic therapy for primary hyperhidrosis: a retrospective study of 59 patients treated with glycopyrrolate or clonidine.
    Walling HW
    J Am Acad Dermatol; 2012 Mar; 66(3):387-92. PubMed ID: 21820204
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyperhidrosis Disease Severity Measure-Axillary (HDSM-Ax): Evaluation of Measurement Performance.
    Hobart J; Burke L; Kirsch B; Chadha D
    J Drugs Dermatol; 2021 Apr; 20(4):410-418. PubMed ID: 33852243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of topical liposome incorporated clove oil in the treatment of idiopathic palmar hyperhidrosis: Single-blinded placebo-controlled study.
    Ibrahim IM; Abdel Kareem IM; Alghobashy MA
    J Cosmet Dermatol; 2018 Dec; 17(6):1084-1089. PubMed ID: 29285889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Efficacy of botulinum toxin A in the treatment of axillary and palmar hyperhidrosis: 10 cases].
    Maillard H; Briand N; Bara C; Celerier P
    Ann Dermatol Venereol; 2003 May; 130(5):511-3. PubMed ID: 12843826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. What stands in the way of treating palmar hyperhidrosis as effectively as axillary hyperhidrosis with botulinum toxin type A.
    Benohanian A
    Dermatol Online J; 2009 Apr; 15(4):12. PubMed ID: 19450405
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A systematic evidence-based review of treatments for primary hyperhidrosis.
    Stuart ME; Strite SA; Gillard KK
    J Drug Assess; 2020 Dec; 10(1):35-50. PubMed ID: 33489435
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of axillary and palmar hyperhidrosis with botulinum toxin.
    Goldman A
    Aesthetic Plast Surg; 2000; 24(4):280-2. PubMed ID: 10954791
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of topical sofpironium bromide gel for the treatment of axillary hyperhidrosis: A phase II, randomized, controlled, double-blinded trial.
    Kirsch B; Smith S; Cohen J; DuBois J; Green L; Baumann L; Bhatia N; Pariser D; Liu PY; Chadha D; Walker P
    J Am Acad Dermatol; 2020 Jun; 82(6):1321-1327. PubMed ID: 32068049
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacology, toxicology and clinical safety of glycopyrrolate.
    Chabicovsky M; Winkler S; Soeberdt M; Kilic A; Masur C; Abels C
    Toxicol Appl Pharmacol; 2019 May; 370():154-169. PubMed ID: 30905688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hyperhidrosis - Sweating Sites Matter: Quality of Life in Primary Hyperhidrosis according to the Sweating Sites Measured by SF-36.
    Shayesteh A; Janlert U; Nylander E
    Dermatology; 2017; 233(6):441-445. PubMed ID: 29502112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-effectiveness of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis.
    Bloudek LM; Gillard KK; Nguyen VB; Klein SZ
    J Med Econ; 2021; 24(1):29-37. PubMed ID: 33256494
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical evaluation of a microwave device for treating axillary hyperhidrosis.
    Hong HC; Lupin M; O'Shaughnessy KF
    Dermatol Surg; 2012 May; 38(5):728-35. PubMed ID: 22452511
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bilateral one-stage single-port sympathicotomy in primary focal hyperhidrosis, a prospective cohort study: treat earlier?
    Kuijpers M; Peeters G; Harms PW; Bouma W; DeJongste MJ; Mariani MA; Klinkenberg TJ
    J Cardiothorac Surg; 2021 Mar; 16(1):50. PubMed ID: 33766091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.